Radiosurgery Global brings the world's most advanced cancer treatment technologies to hospitals, governments and patients across Africa, the Middle East and beyond — making outstanding care accessible wherever it is needed most.
Advanced cancer care should not depend on where you were born. RSG works directly with governments, development finance institutions and hospital groups to fund, build and operate radiation oncology infrastructure in markets where it is most critically needed.
Every technology in our portfolio is FDA cleared, CE marked or internationally certified. We hold ourselves and our partners to the same exacting standards as the world's finest cancer centres.
We are not a distributor. RSG holds exclusive distribution and representation rights for nine world-leading technologies across EMEA and APAC — and we manage every stage of each project from feasibility through to long-term operations and maintenance.
Each section of this site is designed to speak directly to a specific audience. Choose yours below.
A platform of extraordinary capability — delivering every advanced radiotherapy technique with a single, elegant machine. The centrepiece of our Dubai Healthcare City centre and the backbone of our Africa pipeline. First US patient treated at Advanced Radiation Centers of New York, December 2025. U.S. FDA 510(k) Cleared. Now available exclusively through RSG across EMEA and APAC.
The Middle East is investing transformatively in healthcare. Sub-Saharan Africa holds extraordinary potential — and RSG is the partner bringing both regions the clinical technology, financing structures and project expertise to realise it.
Our Dubai Healthcare City Radiotherapy Centre is under active development for a 2026 opening. RSG has signed agreements or is in active project development with government health ministries and hospital groups in Nigeria, Kenya, Egypt, Saudi Arabia, Ghana, Morocco and South Africa.
Explore Our Africa & ME StrategyThe UAE's most advanced radiation oncology facility will open in Dubai Healthcare City in 2026, featuring the Akesis Gemini360RT® LINAC.
Read More →RSG formalises strategic partnerships with hospital groups and health ministries across three key Sub-Saharan African markets.
Read More →RSG adds the FDA-cleared Akesis Gemini360RT® to its global portfolio following the first US patient treatment in December 2025.
See Solutions →Whether you represent a government, hospital group, investment fund or development finance institution — our clinical and commercial team would love to hear from you.
Contact Radiosurgery Global